Da risikoen for skade på spædbørn, der ammes, er ukendt, bør kvinder ikke amme umiddelbart efter behandling med Opgenra.
As the potential for harm to the breast fed infant is unknown, women should not breast-feed during the period immediately following treatment with Opgenra.